farmasino ibrutinib manufacturer

Ibrutinib (936563-96-1) Ibrutinib is a non-receptor Bruton's tyrosine kinase inhibitor approved for the treatment of relapsed chronic lymphocytic leukemia (CLL), mantle cell lymphoma (MCL), and Waldenstrm's Macroglobulinemia (WM). Product Name: Ibrutinib CAS No.: 936563-96-1 Assay: 98% Specification: CP, EP, In-house, as required Molecular Formula: C25 H24 N6 O2 Molecular Weight: 440.5 Shelf Life: 2 Years Package: 25kg/drum

Product Information 5-(4-phenoxyphenyl)-7H-pyrrolo[2,3-d]pyrimidin-4-ylamine (CAS: 330786-24-8) serves as a key intermediate in the synthesis of Ibrutinib, an important pharmaceutical compound. Product Name 5-(4-phenoxyphenyl)-7H-pyrrolo[2,3-d]pyrimidin-4-ylamine CAS Number 330786-24-8 Assay 98% End Use Ibrutinib Intermediate Molecular Formula C17 H13 N5 O Molecular Weight 303.32 g/mol Shelf Life 2 Years Package 25kg/drum Product Documentation

(S)-1-Boc-3-hydroxypiperidine (CAS 143900-44-1) (S)-1-Boc-3-hydroxypiperidine is a key chiral intermediate specifically used in the synthesis of Ibrutinib, an important pharmaceutical compound. This high-purity chemical intermediate is essential for pharmaceutical manufacturing processes. Product Specifications Product Name (S)-1-Boc-3-hydroxypiperidine CAS Number 143900-44-1 Assay 98% End Use Ibrutinib Intermediate Molecular Formula C10 H19 NO3 Molecular Weight 201.26 g/mol

3-(4-Phenoxy-phenyl)-1-piperidin-3-yl-1H-pyrazolo[3,4-d]pyriMidin-4-ylaMine (1022150-12-4) 3-(4-Phenoxy-phenyl)-1-piperidin-3-yl-1H-pyrazolo[3,4-d]pyriMidin-4-ylaMine (1022150-12-4) is a key intermediate of Ibrutinib, serving as a crucial building block in pharmaceutical manufacturing processes. Product Specifications Product Name 3-(4-Phenoxy-phenyl)-1-piperidin-3-yl-1H-pyrazolo[3,4-d]pyriMidin-4-ylaMine CAS No. 1022150-12-4 Assay 98% End Use Ibrutinib Molecular Formula C22